Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1571.4%
Neutral628.6%
Bearish00.0%
CRH plc · CRH · FY2025 Q1 · Calendar Q2 2025
CRH Reaffirms Guidance as Acquisitions Support Growth
The supplied analysis supports a cautiously constructive operating thesis for CRH: management reported year-over-year revenue and adjusted EBITDA growth, reaffirmed guidance, and pointed to infrastructure demand, pricing and acquisitions. The thesis remains conditional on execution against FX, cost, weather, volume and M&A risks.
Reported Before market openNYSEBasic Materials
$54.16B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $-0.06
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $6.73B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-0.3%
Event window
SPY move
-0.6%
Same window
Abnormal move
+0.3%
Stock minus SPY
Volume
1.0×
Versus trailing sessions
Subsequent drift
-7.3%
Up to 20 sessions
CRHSPY benchmark
Ask FN2 about CRH FY2025 Q1
Transcript, numbers and history already loaded
What drove CRH's -0.3% move after FY2025 Q1 earnings?What changed in CRH's guidance and outlook in FY2025 Q1?Give me the bull and bear case for CRH after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the current analysis adds eight Q1 bolt-on acquisitions, continued guidance, stronger stated backlog positioning despite weather, and ongoing shareholder returns. Capex outlook was not mentioned in the current analysis.
Guidance delta
Maintained: management reaffirmed 2025 adjusted EBITDA guidance of $7.3–$7.7 billion.
Key takeaways
- Management described a solid start to 2025 despite adverse weather and seasonal effects.
- Eight Q1 bolt-on acquisitions were identified as supporting expansion in higher-growth markets.
- Infrastructure spending, pricing momentum, and acquisitions remain the main stated growth drivers.
- The transcript analysis indicates backlogs were ahead of prior-year levels.
- The earnings analysis does not establish an EPS or revenue beat or miss.
Management priorities
- Disciplined capital allocation toward high-growth markets and bolt-on acquisitions.
- Operational efficiencies and cost control across U.S. and international businesses.
- Pricing execution and infrastructure demand to support margin expansion.
- Dividend growth and continued share repurchases.
Follow CRH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$81.05Current
$88Low
$125.26Average
$165.6High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 13, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 2, 2026 |
| UBS | Buy | Buy | Maintain | Sep 22, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 2, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 12, 2025 |
| Barclays | Overweight | Overweight | Maintain | Oct 20, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Sep 11, 2025 |
| Stifel | Hold | Buy | Downgrade | Apr 15, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Jan 3, 2023 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 2, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Aug 26, 2016 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2016 |
| B of A Securities | Neutral | Underperform | Upgrade | Apr 24, 2016 |
| HSBC | Buy | Hold | Upgrade | Jan 27, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 15, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $81.05. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $118 | $81.56 | +45.6% | Oct 9, 2026 |
| RBC Capital | Analyst unavailable | $135 | $82 | +66.6% | Oct 9, 2026 |
| Truist Financial | Analyst unavailable | $105 | $81.94 | +29.5% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $106 | $81.94 | +30.8% | Oct 5, 2026 |
| UBS | Analyst unavailable | $135 | $88 | +66.6% | Sep 22, 2026 |
| Wells Fargo | Analyst unavailable | $107 | $90.61 | +32.0% | Sep 9, 2026 |
| Berenberg Bank | Harry Goad | $140 | $92.24 | +72.7% | Sep 8, 2026 |
| D.A. Davidson | Garik Shmois | $137 | $95.79 | +69.0% | Aug 24, 2026 |
| Stephens | Analyst unavailable | $125 | $96 | +54.2% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $132 | $106.21 | +62.9% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $165.6 | $113.05 | +104.3% | Jun 26, 2026 |
| Morgan Stanley | Angel Castillo | $139 | $116.19 | +71.5% | Apr 15, 2026 |
| D.A. Davidson | Analyst unavailable | $120 | $125.17 | +48.1% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $133 | $122.46 | +64.1% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $138 | $131.38 | +70.3% | Jan 13, 2026 |
| UBS | Analyst unavailable | $147 | $122.76 | +81.4% | Jan 8, 2026 |
| Morgan Stanley | Angel Castillo | $140 | $123.68 | +72.7% | Dec 10, 2025 |
| Deutsche Bank | Analyst unavailable | $139 | $119.49 | +71.5% | Dec 8, 2025 |
| Barclays | Adam Seiden | $131 | $117.46 | +61.6% | Oct 20, 2025 |
| UBS | Julian Radlinger | $138 | $117.54 | +70.3% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $134 | $117.85 | +65.3% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $116.34 | +66.6% | Oct 7, 2025 |
| UBS | Analyst unavailable | $140 | $121.1 | +72.7% | Oct 2, 2025 |
| UBS | Analyst unavailable | $152 | $119.9 | +87.5% | Oct 1, 2025 |
| RBC Capital | Anthony Codling | $108 | $85.78 | +33.3% | Apr 14, 2025 |
| Berenberg Bank | Analyst unavailable | $120 | $102.52 | +48.1% | Feb 28, 2025 |
| Truist Financial | Keith Hughes | $110 | $82.79 | +35.7% | Aug 9, 2024 |
| Morgan Stanley | Cedar Ekblom | $88 | $74.23 | +8.6% | Jul 9, 2024 |
| Truist Financial | Keith Hughes | $100 | $83.44 | +23.4% | May 13, 2024 |
| Truist Financial | Keith Hughes | $81 | $67.5 | -0.1% | Dec 14, 2023 |
Track every rating change on CRH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally. It operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company offers building materials for the construction and maintenance of public infrastructure, and commercial and residential buildings, as well as construction and renovation of transportation infrastructure, critical utility networks, commercial and residential buildings, and outdoor living spaces; paving and construction services; and produces and sells aggregates, cementitious materials, ready mixed concrete and mortars, and asphalt.…
Historical context
All CRH earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| RPM RPM International Inc. | FY2027 Q1 · Calendar Q4 2026 | +1.5% | +3.2% | RPM posts record quarter, but input costs narrow the outlook |
Latest beats and misses
Who reports nextBeat on EPS
Get the CRH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-23T11:26:29.967526+00:00
- Polygon adjusted daily market bars · 2026-10-13T03:50:42.521631+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-13T03:50:42.517611+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-13. For educational purposes only; not investment advice.